title: Pellagra, azathioprine and inflammatory bowel disease.
authors.affiliation: Department of Dermatology, Health Waikato, Hamilton, New Zealand.
authors.forename: P
authors.initials: P
authors.lastname: Jarrett
authors.forename: M
authors.initials: M
authors.lastname: Duffill
authors.forename: A
authors.initials: A
authors.lastname: Oakley
authors.forename: A
authors.initials: A
authors.lastname: Smith
mesh_terms: D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009536:Niacinamide / Q000627:therapeutic use; D010383:Pellagra / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents; D009536:Niacinamide; D001379:Azathioprine